F. Brizard

发表

Chromosomal analysis of purified B-chronic lymphocytic leukemia lymphocyte cultures: comparison with whole blood cultures and in situ hybridization.

J. Tanzer, J. Preud’homme, F. Morel, 1993, Leukemia & lymphoma.

Abnormalities of the short arm of chromosome 12 in T cell prolymphocytic leukemia

R. Berger, I. Radford, M. Coniat, 1998, Leukemia.

Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stages.

O. Bernard, C. Bastard, F. Davi, 2010, Leukemia research.

p14ARF, p15INK4b, and p16INK4a methylation status in chronic myelogenous leukemia.

C. Larsen, F. Guilhot, J. Roche, 2003, Blood.

The Rho–ROCK pathway as a new pathological mechanism of innate immune subversion in chronic myeloid leukaemia

A. Herbelin, F. Guilhot, L. Roy, 2016, The Journal of pathology.

Successful second allogeneic stem cell transplantation in second remission induced by dasatinib in a child with Philadelphia chromosome positive acute lymphoblastic leukemia

F. Guilhot, J. Chomel, F. Millot, 2009, Pediatric blood & cancer.

Binding of Bile Acids by Polymerized Cyclodextrin Resins

X. Zhu, G. R. Brown, X. X. Zhu, 1997 .

E2A/HLF fusion gene in an acute lymphoblastic leukemia patient with disseminated intravascular coagulation and a normal karyotype.

L. Daheron, F. Guilhot, F. Millot, 2002, The hematology journal : the official journal of the European Haematology Association.

Identification and genetic characterization of a NUP98-HHEX molecular rearrangement in a pediatric acute myeloid leukemia

C. Mecucci, N. Sorel, J. Chomel, 2021, Leukemia & lymphoma.

Human LPP gene is fused to MLL in a secondary acute leukemia with a t(3;11) (q28;q23)

A Brizard, C. Larsen, H. Drabkin, 2001, Genes, chromosomes & cancer.

Extensive analysis of the T315I substitution and detection of additional ABL mutations in progenitors and primitive stem cell compartment in a patient with tyrosine kinase inhibitor-resistant chronic myeloid leukemia

F. Guilhot, N. Sorel, L. Roy, 2010, Leukemia & lymphoma.

Quantitative monitoring of the T315I mutation in patients with chronic myeloid leukemia (CML).

P. Saulnier, F. Guilhot, N. Sorel, 2009, Leukemia research.

Expression of the cell cycle regulators p14ARF and p16INK4a in chronic myeloid leukemia

C. Larsen, F. Mahon, O. Ayrault, 2006 .

t(3;17)(q21;q25) in Epstein‐Barr virus associated peripheral T‐cell lymphoma: a paediatric case

E. Macintyre, P. Babin, C. Ricour, 1998, British journal of haematology.

ETV6 (TEL) gene amplification in a myelodysplastic syndrome with excess of blasts

N. Sorel, M. Lessard, B. Lioure, 2004, Leukemia.

Persistence of Transcriptionally Silent BCR-ABL Rearrangements in Chronic Myeloid Leukemia Patients in Sustained Complete Cytogenetic Remission

A. Kitzis, J. Chomel, A. Brizard, 2001, Leukemia & lymphoma.

Interstitial telomere repeats in translocations of hematopoietic disorders

R. Berger, O. Maarek, H. Sarkissian, 2000, Leukemia.

Ovarian sarcoma and acute myelogenous leukaemia.

F. Guilhot, V. Delwail, A. Brizard, 2001, The hematology journal : the official journal of the European Haematology Association.

Longitudinal clonal architecture of acute myeloid leukemia with NPM1 driver insertion, early TET2 mutations and secondary e6a2 BCR-ABL1 rearrangement

X. Leleu, N. Sorel, J. Chomel, 2020, Leukemia & lymphoma.

Additional cytogenetic abnormalities and variant t(9;22) at the diagnosis of childhood chronic myeloid leukemia: The experience of the International Registry for Chronic Myeloid Leukemia in Children and Adolescents

A. Baruchel, T. Leblanc, Chi-kong Li, 2017, Cancer.

Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-alpha therapy or allogeneic bone marrow transplantation.

A. Kitzis, F. Guilhot, J. Chomel, 2000, Blood.

p190(BCR-ABL) rearrangement as a secondary change in a case of acute myelo-monocytic leukemia with inv(16)(p13q22).

F. Guilhot, N. Sorel, A. Brizard, 2004, Leukemia research.

Aml1/ETO and Pml/RARA rearrangements in a case of AML-M2 acute myeloblastic leukemia with t(15;17).

G. Flandrin, H. Drabkin, J. Roche, 1999, Leukemia & lymphoma.

Long‐term molecular remission in a patient with acute myeloid leukemia harboring a new NUP98‐LEDGF rearrangement

X. Leleu, N. Sorel, J. Chomel, 2019, Cancer medicine.

Proliferative response of B chronic lymphocytic leukemia lymphocytes stimulated with IL2 and soluble CD23.

J. Preud’homme, F. Morel, A. Brizard, 1994, Leukemia & lymphoma.

Trisomy 8q due to i(8q) or der(8) t(8;8) is a frequent lesion in T‐prolymphocytic leukaemia: four new cases and a review of the literature

J. Huret, J. Tanzer, H. Mossafa, 1994, British journal of haematology.

Does BCR-ABL genomic rearrangement persist in CML patients in complete remission after interferon α therapy?

A. Kitzis, F. Guilhot, J. Chomel, 1998, Leukemia.

11q13 rearrangement in B cell chronic lymphocytic leukemia.

J. Tanzer, F. Guilhot, A. Brizard, 1997, Leukemia & lymphoma.

SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia

C. Deswarte, E. Pasmant, I. Laurendeau, 2014, Oncogene.

Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia

A. Baron, S. Hunger, R. Gemmill, 2002, Leukemia.

Multiple chromosomal mechanisms generate an EWS/FLI1 or an EWS/ERG fusion gene in Ewing tumors.

G. Thomas, O. Delattre, A. Aurias, 1997, Cancer genetics and cytogenetics.

Fluorescence in situ hybridization analysis of chromosome 1 abnormalities in hematopoietic disorders: rearrangements of DNA satellite II and new recurrent translocations

R. Berger, O. Bernard, N. Dastugue, 1999, Leukemia.

A complex pattern of recurrent chromosomal losses and gains in T‐cell prolymphocytic leukemia

F. Sigaux, J. Soulier, A. Aurias, 2001, Genes, chromosomes & cancer.

Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?

R. Berger, L. Michaux, V. Eclache, 2007, Cancer genetics and cytogenetics.

Genomic organization of the human and mouse stau genes.

L. DesGroseillers, M. Luo, F. Brizard, 2000, DNA and cell biology.

Comparison of M-FISH and conventional cytogenetic analysis in accelerated and acute phases of CML.

F. Guilhot, A. Brizard, F. Brizard, 2004, Leukemia research.

Recurrence of childhood acute lymphoblastic leukemia presenting as a tumor of the middle ear: a case report.

J. Klossek, P. Babin, F. Guilhot, 1997, Journal of pediatric hematology/oncology.

Unclassifiable high grade malignant T-cell lymphoma with clonal evolution.

J. Tanzer, P. Babin, F. Guilhot, 1994, Leukemia & lymphoma.

Detection of monosomy 7 and trisomies 8 and 11 in myelodysplastic disorders by interphase fluorescent in situ hybridization. Comparison with acute non-lymphocytic leukemias.

R. Berger, J. Tanzer, F. Guilhot, 1994, Leukemia.

C. Preudhomme, F. Guilhot, N. Sorel, 2005, Leukemia & lymphoma.

Endoscopic diagnosis of childhood Burkitt's lymphoma of the colon.

F. Guilhot, F. Millot, P. Levillain, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Unique association of systemic mastocytosis and myeloid/lymphoid neoplasm in blast crisis with abnormality of FGFR1 gene.

N. Sorel, C. Mayeur‐Rousse, A. Turhan, 2012, Leukemia research.

Treatment and molecular monitoring update in chronic myeloid leukemia management.

N. Sorel, J. Chomel, F. Brizard, 2017, Annales de biologie clinique.